Dr. Sarabjeet Singh Suri, MD

Dr. Suri practices at Jewish Hospital and St Mary's Healthcare - HOPD in Louisville, Kentucky.

Dr. Suri's NPI, 1174079404, was assigned on August 28, 2016. Dr. Suri holds Kentucky license 55062.

Dr. Suri's primary practice is Jewish Hospital and St Mary's Healthcare - HOPD, at 200 Abraham Flexner Way, Louisville, KY 40202.

Dr. Suri's primary practice is Jewish Hospital and St Mary's Healthcare - HOPD in Louisville, Kentucky. Dr. Suri is also affiliated with UofL Health - Jewish Hospital. The medical group on file is Southeastern Emergency Physicians. Dmand AI also links Dr. Suri to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Suri practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Suri's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Suri is licensed in Kentucky.

CMS data shows 339 Medicare services from Dr. Suri across 8 procedure codes in 2024, for 174 Medicare patients. Medicare paid $21,035 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 174 Medicare patients who saw Dr. Suri in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Suri's median patient age at 72, with 50% women.

In 2024, Dr. Suri wrote 98 Medicare Part D claims for 31 patients. 86% of them were for generic drugs. CMS names the drug for 23 of them, across 2 drugs with 11 or more claims each, at $193 in total drug cost. In 2022, CMS named 69 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Suri for performance year 2024, reported through an alternative payment model (APM). Dr. Suri accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 114 general payments to Dr. Suri from 29 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 71% of the total. Abbott Laboratories paid the most, $2,403.